Bottom line
FFTY vs BOUT: the short answer
FFTY (Innovator IBD(R) 50 ETF) and BOUT (CapForce IBD Breakout Opportunities ETF) are both etfs.
Updated Nov 19, 2026
FFTY vs BOUT side by side
| FFTY | BOUT | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Innovator | Capforce Ibd Breakout Opportunities |
| Category | Other | Other |
| Expense ratio | 0.8% | — |
| Annual cost per $10k | $80 | — |
| 10-yr cost on $10k (prospectus) | $1,239 | — |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +23.5% | — |
| 5-yr return (annualized) | −2.1% | — |
| 10-yr return (annualized) | +5.3% | — |
| Best quarter | +23.2% | — |
| Worst quarter | −31.2% | — |
| Net assets (fund) | — | — |
| Number of holdings | — | — |
| Portfolio turnover | 1,209% | — |
| Returns as of | Dec 31, 2024 | — |
Source: SEC Form N-PORT and fund prospectuses
FAQ
What is the difference between FFTY and BOUT?
FFTY (Innovator IBD(R) 50 ETF) and BOUT (CapForce IBD Breakout Opportunities ETF) are both etfs.
Should I own both FFTY and BOUT?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.